NCT00001188已完成2 期
The Role of Multi-Modality Therapy for the Treatment of High-Grade Soft Tissue Sarcomas of the Extremities
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 100
- 试验地点
- 1
研究概览
简要总结
Patients with Grade II and III soft tissue sarcomas of the extremity will be randomized to either receive or not receive radiation therapy following surgery for the removal of the local tumor. All patients in this protocol will receive adjuvant chemotherapy.
详细描述
Patients with Grade II and III soft tissue sarcomas of the extremity will be randomized to either receive or not receive radiation therapy following surgery for the removal of the local tumor. All patients in this protocol will receive adjuvant chemotherapy.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients must have biopsy-proven soft tissue sarcoma with one of the following diagnoses:
- •Liposarcoma (round cell or pleomorphic).
- •Fibrosarcoma.
- •Malignant fibrous histiocytoma.
- •Inflammatory malignant fibrous histiocytoma.
- •Myxoid malignant fibrous histiocytoma.
- •Malignant giant cell tumor.
- •Angiomatoid malignant fibrous histiocytoma.
- •Leiomyosarcoma.
- •Malignant hemangiopericytoma.
- •Rhabdomyosarcoma (embryonal, alveolar, pleomorphic or combined).
- •Soft tissue sarcoma resembling Ewing's sarcoma.
- •Synovial cell sarcoma.
- •Epithelioid sarcoma.
- •Clear cell sarcoma.
- •Neurofibrosarcoma.
- •Epithelioid schwannoma.
- •Malignant triton tumor.
- •Angiosarcoma.
- •Mixed malignant mesenchymoma.
- •Alvelar soft part sarcoma.
- •Malignant granular cell tumor.
- •All lesions must be Grade II or III. No patients with Grade I lesions will be acceptable.
- •Patients must have undergone a limb-sparing procedure in which all gross tumor has been removed.
- •Clinical evaluation must reveal no evidence of metastatic disease either in regional lymph nodes or more distant sites.
- •The soft tissue sarcoma must be on the extremity either at or distal to the shoulder joint or at or distal to the hip joint.
- •The definitive surgical procedure for a primary lesion or for a recurrence must have been performed no longer than four months from the date of randomization.
- •Patients must not have received any prior chemotherapy or radiotherapy for their sarcoma.
- •Patients without a history of any other malignant disease except basal cell carcinoma.
- •Patients who have not had a serious infection, active bleeding disorders, or concomitant severe disease such as cirrhosis, ischemic heart disease, or evidence of severe impairment of renal function.
- •Patients must be above the age of 30 and do not have a diagnosis of embryonal rhabdomyosarcoma.
排除标准
- 未提供
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Evaluation of Adaptive Radiation Therapy in Pre-operative or Exclusive Radiation Therapy for Limb Soft Tissues SarcomasSarcoma, Soft TissueNCT03680430Institut Paoli-Calmettes61
招募中
不适用
Combined Treatment of Patients With Soft Tissue Sarcoma Including Preoperative Stereotactic Radiation Therapy and Postoperative Conformal Radiation TherapySoft Tissue Sarcoma AdultNCT04330456N.N. Petrov National Medical Research Center of Oncology30
已完成
3 期
Localized High-Risk Soft Tissue Sarcomas Of The Extremities And Trunk Wall In Adults: An Integrating Approach Comprising Standard Vs Histotype-Tailored Neoadjuvant ChemotherapyLocalized High-risk Soft Tissue Sarcomas of the Extremities and Trunk Wall in AdultsNCT01710176Italian Sarcoma Group550
Unknown
2 期
Dexmedetomidine Sedation in Orthopedic SurgeryHallux Valgus and BunionSedationNCT04149626Asklepieion Voulas General Hospital60
已完成
3 期
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue SarcomaChildhood FibrosarcomaChildhood LiposarcomaMetastatic Childhood Soft Tissue SarcomaAdult Extraskeletal OsteosarcomaAdult Malignant Fibrous HistiocytomaNonmetastatic Childhood Soft Tissue SarcomaStage I Adult Soft Tissue SarcomaStage III Adult Soft Tissue SarcomaAdult AngiosarcomaAdult Epithelioid SarcomaAdult Extraskeletal ChondrosarcomaAdult LeiomyosarcomaChildhood Epithelioid SarcomaStage IV Adult Soft Tissue SarcomaAdult Malignant MesenchymomaChildhood LeiomyosarcomaChildhood Synovial SarcomaAdult Alveolar Soft-part SarcomaAdult Malignant HemangiopericytomaAdult NeurofibrosarcomaChildhood AngiosarcomaChildhood NeurofibrosarcomaStage II Adult Soft Tissue SarcomaAdult FibrosarcomaAdult LiposarcomaAdult Synovial SarcomaChildhood Alveolar Soft-part SarcomaChildhood Malignant MesenchymomaDermatofibrosarcoma ProtuberansNCT00346164Children's Oncology Group588